Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort.

Yuen KCJ, Vila G, Bernabeu I, Buchfelder M, Freda P, Henocque R, Torre D, Maffei P, Strasburger CJ, Neggers S, Brue T

DOI: 10.1007/s11102-026-01673-x
Published: 2026 Apr 15
Container: Pituitary
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11102-026-01673-x,
  title = {Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort.},
  author = {Yuen KCJ and Vila G and Bernabeu I and Buchfelder M and Freda P and Henocque R and Torre D and Maffei P and Strasburger CJ and Neggers S and Brue T},
  year = {2026},
  journal = {Pituitary},
  doi = {10.1007/s11102-026-01673-x},
  url = {https://doi.org/10.1007/s11102-026-01673-x}
}

RIS

TY  - JOUR
TI  - Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort.
AU  - Yuen KCJ
AU  - Vila G
AU  - Bernabeu I
AU  - Buchfelder M
AU  - Freda P
AU  - Henocque R
AU  - Torre D
AU  - Maffei P
AU  - Strasburger CJ
AU  - Neggers S
AU  - Brue T
PY  - 2026
JO  - Pituitary
DO  - 10.1007/s11102-026-01673-x
UR  - https://doi.org/10.1007/s11102-026-01673-x
ER  -

APA

KCJ, Y., G, V., I, B., M, B., P, F., R, H., D, T., P, M., CJ, S., S, N., & T, B. (2026). Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort.. Pituitary. https://doi.org/10.1007/s11102-026-01673-x

Source records

pubmed · retrieved 2026-09-25T07:44:27.352Z